Picture of BRAIN Biotech AG logo

BNN BRAIN Biotech AG News Story

0.000.00%
de flag iconLast trade - 00:00
IndustrialsHighly SpeculativeSmall CapMomentum Trap

Brief: Brain First Development Phase For Novel Genome Editing Tool Completed (CRISPR Cas)

May 6 (Reuters) - BRAIN BIOTECH AG  BNNn.DE :
    * FIRST DEVELOPMENT PHASE FOR A NOVEL GENOME EDITING TOOL
COMPLETED (CRISPR CAS)
    * SUCCESSFULLY COMPLETED FIRST DEVELOPMENT PHASE FOR A NOVEL
GENOME EDITING TOOL BASED ON A NON-CAS9 NUCLEASE

Source text for Eikon:  ID:nEQ5M5Nksa 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))

Recent news on BRAIN Biotech AG

See all news